You can read the full article atYou can read the full article at Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30-week, double-blind, phase 3a, randomized trial Due to increased obesity and inactivity rates, type 2 diabetes (T2D) is a complex, multifaceted disease with a rising prevalence rate
doi:10.2147/ijn.S478589 Samad MB, Mohsin M, Razu BA, et al
With the right combination of injectables, bio-stimulatory treatments, advanced technology, and medical-grade skincare, patients can achieve natural, confidence-boosting results without surgery
Ideal Candidates Tirzepatide is suitable for adults with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who have at least one weight-related comorbidity, such as hypertension, type 2 diabetes, or dyslipidemia
Possible Risks and Concerns Even though there is no known direct drug interaction between semaglutide and Topiramate, combining them can increase the risk of side effects
It also says the $50 copay does not count toward your Part D true out-of-pocket costs